HIGHLIGHTS
- who: Felipe Pantoja Mesquita and collaborators from the Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Cearu00e1, Fortaleza, CE, Brazil have published the Article: Kinase Inhibitor Screening Displayed ALK as a Possible Therapeutic Biomarker for Gastric Cancer, in the Journal: Pharmaceutics 2022, 1841 of 22/03/2022
- what: Taking all together, this study aimed to evaluate possible novel kinase targets in malignant gastric cells to identify a new therapeutic strategy based on kinase inhibition using PKIs library.
- how: Looking for another evidence that ALK can be a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.